Novo Nordisk A/S logo NVO - Novo Nordisk A/S

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 24
HOLD 11
SELL 3
STRONG
SELL
0
| PRICE TARGET: $55.00 DETAILS
HIGH: $70.00
LOW: $47.00
MEDIAN: $51.50
CONSENSUS: $55.00
DOWNSIDE: 11.76%
Market Cap: 277.06B
Volume: 43,044,795
Avg Volume: 19,198,988
52 Week Range: 43.08-93.8
Sector: Healthcare
Industry: Drug Manufacturers - General
Beta: 0.36
Last Dividend: $1.23
Exchange: NYSE
Country: DK
Employees: 77,406
IPO Date: 1981-04-30
EPS (TTM): 22.67
P/E Ratio: 27.33
Revenue (TTM): 290.40B
Total Assets: 465.80B
Total Debt: 102.79B
Cash & Equiv: 15.65B
Rev Growth (5Y): 18.9%
EPS Growth (5Y): 22.5%
FCF Growth (5Y): 14.4%
ROCE: 51.9%
Debt/Equity: 0.72

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 290.40B 232.26B 176.95B 140.80B 126.95B 122.02B 111.83B 111.70B 111.78B 107.93B 88.81B 83.57B
Net Income 100.99B 83.68B 55.52B 47.76B 42.14B 38.95B 38.63B 38.13B 37.92B 34.86B 26.48B 25.18B
EPS 22.67 18.67 12.26 10.40 9.03 8.21 7.98 7.71 7.50 6.78 5.05 4.70
Total Assets 465.80B 314.49B 241.26B 194.51B 23.82B 18.87B 110.77B 102.36B 97.54B 91.80B 77.06B 70.34B
Total Debt 102.79B 27.01B 25.78B 26.64B 1.70B 673.43M 515.00M 1.69B 229.00M 1.07B 720.00M 215.00M
Cash & Equivalents 15.65B 14.39B 12.65B 10.72B 2.10B 2.32B 15.64B 18.85B 18.69B 16.92B 14.40B 10.73B
Operating Cash Flow 120.97B 108.91B 78.89B 55.00B 51.95B 46.78B 44.62B 41.17B 48.31B 38.29B 31.69B 25.94B
Free Cash Flow 69.66B 70.01B 64.13B 47.62B 29.87B 35.55B 32.21B 32.52B 40.05B 31.88B 27.36B 22.30B
FCF per Share 15.64 15.62 14.16 10.37 6.40 7.49 6.66 6.56 7.90 6.18 5.20 4.14
Book Value 143.49B 106.56B 83.49B 70.75B 10.41B 8.65B 51.84B 49.81B 45.27B 46.97B 40.29B 42.57B
Cash & ST Investments 26.31B 30.23B 23.57B 17.48B 2.10B 2.32B 15.64B 18.85B 20.70B 20.46B 15.90B 14.47B
ROC Equity 0.70 0.79 0.67 0.68 4.05 4.50 0.75 0.77 0.84 0.74 0.66 0.59